TORNTPHARMNSETorrent Pharmaceuticals Limited· PharmaceuticalsHighNeutral
Announced Wed, 24 Sept · 18:54 IST

Torrent Pharmaceuticals Limited has informed the Exchange about issue of Securities

Fund Raising View source PDF

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Torrent Pharmaceuticals has issued Commercial Papers (CPs) amounting to ₹200 Crores on September 24, 2025. The CPs carry a short tenure of 90 days, maturing on December 23, 2025, with a coupon rate of 5.93% per annum paid upfront. The instrument is unsecured and is proposed to be listed on the NSE. Principal repayment is scheduled at maturity. This is a routine short-term money market borrowing, typically used to meet working capital needs.

Likely market impact

This is a small, short-term debt raise at a competitive interest rate, unlikely to materially affect the stock price or shareholders. It signals routine treasury management rather than any significant capital event.